| 摘要 |
This invention relates to a method of determining information about the likely clinical outcome of a microbiological infection in a patient, and also to a method of selecting a suitable therapeutic regimen for a patient with a microbiological infection. Accordingly, in one aspect, the present invention provides a method of determining the likely clinical outcome of a microbiological infection in a patient comprising: (a) analysing a sample taken from said patient for the presence of a target micro-organism, by the characterisation of a target nucleic acid sequence therein; and (b) analysing a sample taken from said patient for the presence of one or more disease susceptibility markers in the genome of said patient. Alternatively viewed, in another aspect, the present invention provides a method of selecting a suitable therapeutic regimen for a patient comprising: (a) analysing a sample taken from said patient for the presence of a target micro-organism, by the characterisation of a target nucleic acid sequence therein; and (b) analysing a sample taken from said patient for the presence of one or more disease susceptibility markers in the genome of said patient.
|
